Vancomycin hydrochloride and Febrile neutropenia - a phase IV clinical study of FDA data
Febrile neutropenia is found among people who take Vancomycin hydrochloride, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Vancomycin hydrochloride and have Febrile neutropenia. It is created by eHealthMe based on reports of 5,274 people who have side effects when taking Vancomycin hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
5,274 people reported to have side effects when taking Vancomycin hydrochloride.
Among them, 160 people (3.03%) have Febrile neutropenia.
What is Vancomycin hydrochloride?
Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 5,459 Vancomycin hydrochloride users for its effectiveness, alternative drugs and more.
What is Febrile neutropenia?
Febrile neutropenia (fever with reduced white blood cells) is found to be associated with 1,918 drugs and 1,688 conditions by eHealthMe.
Number of Vancomycin hydrochloride and Febrile neutropenia reports submitted per year:
Time on Vancomycin hydrochloride when people have Febrile neutropenia *:
Gender of people who have Febrile neutropenia when taking Vancomycin hydrochloride*:
Age of people who have Febrile neutropenia when taking Vancomycin hydrochloride *:
Common drugs people take besides Vancomycin hydrochloride *:
Common side effects people have besides Febrile neutropenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Vancomycin hydrochloride and have Febrile neutropenia?Check whether Febrile neutropenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Alternative drugs to, pros and cons of Vancomycin hydrochloride:
- Vancomycin hydrochloride (5,459 reports)
Febrile neutropenia treatments and more:
- Febrile neutropenia (59,478 reports)
COVID vaccines that are related to Febrile neutropenia:
- Febrile neutropenia in Moderna COVID Vaccine
- Febrile neutropenia in Pfizer BioNTech Covid Vaccine
- Febrile neutropenia in Johnson and Johnson Covid Vaccine
How severe was Febrile neutropenia and when was it recovered:
Expand to all the drugs that have ingredients of vancomycin hydrochloride:
Common drugs associated with Febrile neutropenia:
All the drugs that are associated with Febrile neutropenia:
- Febrile neutropenia (1,918 drugs)
Common conditions associated with Febrile neutropenia:
All the conditions that are associated with Febrile neutropenia:
- Febrile neutropenia (1,688 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on vancomycin hydrochloride (the active ingredients of Vancomycin hydrochloride) and Vancomycin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.